Christopher Carl Bolten

Chris Bolten is a globally recognized IP attorney focusing on MedTech and technology fields. Chris represents 55+ MedTech companies and VCs in the medical device and digital health industries-including those utilizing artificial intelligence (AI)-across the United States, Europe, Israel, and Asia. He has handled over 100 IP diligences for premiere venture capital firms and for MedTech companies. Chris served as IP counsel for the company or investors in the #1 and #2 MedTech acquisitions of private companies in 2024, the #1 overall MedTech acquisitions in 2022 and 2024, and the largest MedTech acquisition in the history of Israel, amongst many others. Over 15+ years in MedTech, his clients have been acquired by strategics for multi-billions of dollars. Having litigated dozens of patent cases in federal court across the United States for MedTech companies and other household name companies, Chris builds litigation-ready IP to facilitate investment, acquisition, and enforcement.

Chris handles matters involving technologies like structural heart devices, stents, shunts, prosthetic heart valves, catheters, robotics, AI, neurovascular, peripheral and cardiovascular, connected health, wearable devices, spine, surgery, orthopedics, interventions, electrophysiology, ophthalmology, women’s health, dental, neuromodulation, ablation, wound healing, diagnostics, drug delivery, microfluidics, software, cloud computing, networks for AI, and internet systems. His experience includes IP portfolio strategy, patent prosecution, FTO opinions, and litigation.

Concentrations

•Patent portfolio management and strategic counseling
•IP due diligence for venture capital firms and companies
•MedTech-medical devices, digital health, artificial intelligence (AI)
•Litigation and pre-litigation strategy

Recognition & Leadership

Awards & Accolades

•Shortlisted, LMG Life Sciences, 'Patent Strategy Attorney of the Year, California,' 2025
•Listed, LMG Life Sciences, 'Life Science Star,' 2025
•Listed, IAM magazine, “IAM Patent 1000,” Prosecution, 2025
•Listed, Chambers USA Guide, Intellectual Property: Patent Prosecution, 2022-2025
•Listed, The Legal 500 United States, 2017, 2020, 2023, and 2025
•Recommended, Patent Prosecution, 2020, 2023, and 2025
•“Next Generation Lawyer,” Patent Prosecution, 2017
•Listed, Super Lawyers magazine, “San Diego Super Lawyers,” 2015-2022